ArticleBlood advances2023

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.

Maciej Tatarczuch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.